|7459444||Inhibitors of chymase|
The present invention is directed to a compound of formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof, and methods for treating inflammatory and serine protease mediated ...
|7459461||Phosphonic acid compounds as inhibitors of serine proteases|
The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders. ...
|5834025||Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions|
Disclosed are methods of intravenous administration of nanoparticulate drug formulations to a mammal to avoid adverse hemodynamic effects: by reducing the rate and concentration of the nanoparticles in the formulations; or by pre-treating the subject with...